Aurand v. Norfolk Southern Railway Co.

802 F. Supp. 2d 950, 2011 WL 2938447
CourtDistrict Court, N.D. Indiana
DecidedJuly 18, 2011
DocketCause Nos. 3:08-CV-398-PPS, 3:08-CV-480-PPS, 3:08-CV-485-PPS
StatusPublished
Cited by11 cases

This text of 802 F. Supp. 2d 950 (Aurand v. Norfolk Southern Railway Co.) is published on Counsel Stack Legal Research, covering District Court, N.D. Indiana primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Aurand v. Norfolk Southern Railway Co., 802 F. Supp. 2d 950, 2011 WL 2938447 (N.D. Ind. 2011).

Opinion

OPINION AND ORDER

PHILIP P. SIMON, Chief Judge.

Plaintiffs Aurand, Gilliland and Lipp each bring suit against defendant Norfolk Southern Railway Company under the Federal Employers’ Liability Act, alleging that the railroad’s negligence in operating the railyard where the plaintiffs worked caused each of them to develop a form of cancer from exposure to dangerous chemicals. Plaintiffs Aurand and Lipp developed multiple myeloma. Plaintiff Gilliland developed chronic lymphocytic leukemia. The three plaintiffs are represented by the same counsel, and the same attorneys represent Norfolk Southern in each case so I have informally consolidated the disposition of these eases into one opinion. The railroad has filed four virtually identical motions in each of the three cases: 1) a motion to exclude the expert report and testimony of plaintiffs’ witness, Richard Lipsey, Ph.D.; 2) a motion to strike any references to the report or opinions of plaintiffs’ withdrawn expert, Dr. Barry Levy; 3) a motion for summary judgment; and 4) a motion for oral argument on the three intertwined motions.1

The summary judgment motion contends that plaintiffs lack the necessary expert evidence supporting both general and specific causation. Norfolk Southern says this is because Dr. Lipsey’s opinion is inadmissible, and each of plaintiffs treating physicians cannot express a causation opinion because no expert report was disclosed. Plaintiffs argue that Dr. Lipsey’s testimony survives the railroad’s challenge and that no expert report was required of the treating physicians because their causation opinion was formed during the course of their treatment of each plaintiff-patient.2

I. NORFOLK’S CHALLENGE TO PLAINTIFFS’ EXPERTS

A. Causation and Expert Testimony Generally

Dr. Lipsey is proffered by the three plaintiffs as an expert forensic toxicologist to testify on the issue of causation. Norfolk Southern argues that the methodology supporting Dr. Lipsey’s conclusions fails to meet the criteria for admissibility under Rule 702 of the Federal Rules of Evidence and the Supreme Court’s decision in Daubert v. Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 113 S.Ct. 2786, 125 L.Ed.2d 469 (1993). Fed.R.Evid. 702 permits opinion testimony by persons with “scientific, technical or other specialized knowledge [that] will assist the trier of fact to understand the evidence or to determine a fact in issue” if “(1) the testimony is based [953]*953upon sufficient facts or data, (2) the testimony is the product of reliable principles and methods, and (3) the witness has applied the principles and methods reliably to the facts of the case.”

In a FELA context, the Seventh Circuit has held that “when there is no obvious origin to an injury and it has ‘multiple potential etiologies, expert testimony is necessary to establish causation.’ ” Myers v. Illinois Central Railroad Company, 629 F.3d 639, 643 (7th Cir.2010) (quoting Wills v. Amerada Hess Corp., 379 F.3d 32, 46-47 (2nd Cir.2004)). And a toxic tort plaintiff must adduce evidence of both general and specific causation. See, e.g., Avila v. Willits Environmental Remediation Trust, 633 F.3d 828, 836 (9th Cir.2011); Junk v. Terminix Intern. Co., 628 F.3d 439, 450 (8th Cir.2010). General causation addresses whether a particular agent can cause a particular illness. Milward v. Acuity Specialty Products Group, Inc., 639 F.3d 11, 13 (1st Cir.2011). Specific causation addresses whether that agent in fact caused the particular plaintiffs illness. Id.

So in toxic tort cases like this one “there is a two-step process in examining the admissibility of causation evidence in toxic tort cases. First, the district court must determine whether there is general causation. Second, if it concludes that there is admissible general-causation evidence, the district court must determine whether there is admissible specific-causation evidence.” Knight v. Kirby Inland Marine Inc., 482 F.3d 347, 351 (5th Cir.2007); see also LeBlanc v. Chevron USA, Inc., 396 Fed.Appx. 94, 97 (5th Cir.2010) (“The LeBlanc family was therefore obligated to provide both a ‘general’ and a ‘specific’ causal link between the benzene exposure and the onset of Mr. LeBlanc’s [disease].”). Lennon v. Norfolk and Western Railway Company, 123 F.Supp.2d 1143, 1154 (N.D.Ind.2000) (Sharp, J., noting that differential diagnosis, as a specific causation tool, “assumes that general causation has been proven”).

Daubert itself was a toxic tort case in which plaintiffs offered experts in support of their theory that the ingestion of the anti-nausea drug Bendectin during pregnancy caused limb reduction birth defects. The Supreme Court remanded for further consideration in light of its conclusion that Fed.R.Evid. 702, and the rule’s requirement that scientific testimony be relevant and reliable, superseded the “general acceptance” test associated with Frye v. United States, 293 F. 1013, 54 App.D.C. 46, 47 (1923). Daubert, 509 U.S. at 587, 589, 598, 113 S.Ct. 2786. The Supreme Court’s discussion of applicable principles included the observation that when Rule 702 admits opinion testimony based on scientific knowledge, “ ‘scientific’ implies a grounding in the methods and procedures of science,” and “ ‘knowledge’ connotes more than subjective belief or unsupported speculation.” Id. at 590, 113 S.Ct. 2786.

After remand by the Supreme Court, the Ninth Circuit in Daubert II considered the admissibility of the plaintiffs’ expert testimony, noting that “[o]ur task ... is to analyze not what the experts say, but what basis they have for saying it.” Daubert v. Merrell Dow Pharm., Inc. (Daubert II), 43 F.3d 1311, 1316 (9th Cir.1995). Courts are warned against the blind acceptance of a scientific expert’s assurance that his conclusions are supported by reliable science. “[Sjomething doesn’t become ‘scientific knowledge’ just because it’s uttered by a scientist; nor can an expert’s self-serving assertion that his conclusions were ‘derived by the scientific method be deemed conclusive.’ ” Id. at 1315-16.

Where, as here, the proffered expert has not conducted research of his own but offers opinions based upon the work and [954]*954conclusions of other scientists, the Supreme Court’s caution in Dauberb

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Myra Duby as Guardian of L.H., a Minor v. Christopher Woolf
76 N.E.3d 190 (Indiana Court of Appeals, 2017)
Higgins v. Koch Development Corp.
997 F. Supp. 2d 924 (S.D. Indiana, 2014)
Deborah Kay Harris, Administratrix v. CSX Transportation
753 S.E.2d 275 (West Virginia Supreme Court, 2013)
Gresser v. Dow Chemical Co.
989 N.E.2d 339 (Indiana Court of Appeals, 2013)
Bombardiere v. Schlumberger Technology Corp.
934 F. Supp. 2d 843 (N.D. West Virginia, 2013)
Richardson v. Union Pacific Railroad
386 S.W.3d 77 (Court of Appeals of Arkansas, 2011)

Cite This Page — Counsel Stack

Bluebook (online)
802 F. Supp. 2d 950, 2011 WL 2938447, Counsel Stack Legal Research, https://law.counselstack.com/opinion/aurand-v-norfolk-southern-railway-co-innd-2011.